Units of Bayer, Germany’s largest drugmaker, may have sought to market the Yasmin family of birth- control pills for unapproved uses and misled women about the health risks the drug posed, according to company e-mails.
Bayer may have pitched birth-control pill for unapproved use
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.